Broad spectrum identification of SUMO substrates in melanoma cells

被引:27
作者
Ganesan, Anand K.
Kho, Yoonjung
Kim, Sung Chan
Chen, Yue
Zhao, Yingming
White, Michael A.
机构
[1] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA
[2] Univ Texas, SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75235 USA
[3] Univ Texas, SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75235 USA
关键词
BRAF; melanoma; signal transcluction; SUMO;
D O I
10.1002/pmic.200600971
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Like phosphorylation, protein sumoylation likely represents a dynamic PTM to alter protein function in support of cell regulatory systems. The broad-spectrum impact of transient or chronic engagement of signal transduction cascades on protein sumoylation has not been explored. Here, we find that epidermal growth factor (EGF) stimulation evokes a rapid alteration in small ubiquitin modifier (SUMO) target selection, while oncogene expression alters steady-state SUMO-protein profiles. A proteomic SUMO target analysis in melanoma cells identified proteins involved in cellular signaling, growth control, and neural differentiation.
引用
收藏
页码:2216 / 2221
页数:6
相关论文
共 50 条
[1]   Neuroscience - SUMO wrestles the synapse [J].
Beg, AA ;
Scheiffele, P .
SCIENCE, 2006, 311 (5763) :962-963
[2]   Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes [J].
Bloethner, Sandra ;
Hemminki, Kari ;
Thirumaran, Ranjit K. ;
Chen, Bowang ;
Mueller-Berghaus, Jan ;
Ugurel, Selma ;
Schadendorf, Dirk ;
Kumar, Rajiv .
MELANOMA RESEARCH, 2006, 16 (04) :297-307
[3]  
Boddy MN, 1996, ONCOGENE, V13, P971
[4]   Novel biomarkers in malignant melanoma [J].
Bosserhoff, AK .
CLINICA CHIMICA ACTA, 2006, 367 (1-2) :28-35
[5]  
Breslow A, 1980, Pathol Annu, V15, P1
[6]   Integrated approach for manual evaluation of peptides identified by searching protein sequence databases with tandem mass spectra [J].
Chen, Y ;
Kwon, SW ;
Kim, SC ;
Zhao, YM .
JOURNAL OF PROTEOME RESEARCH, 2005, 4 (03) :998-1005
[7]   Cooperative effects of INK4a and ras in melanoma susceptibility in vivo [J].
Chin, L ;
Pomerantz, J ;
Polsky, D ;
Jacobson, M ;
Cohen, C ;
CordonCardo, C ;
Horner, JW ;
DePinho, RA .
GENES & DEVELOPMENT, 1997, 11 (21) :2822-2834
[8]   Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer [J].
Debniak, T ;
Gorski, B ;
Scott, RJ ;
Cybulski, C ;
Medrek, K ;
Zlowocka, E ;
Kurzawski, G ;
Debniak, B ;
Kladny, J ;
Bielecka-Grzela, S ;
Maleszka, R ;
Luminski, J .
INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (04) :558-562
[9]   Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds [J].
Flores, JF ;
Pollock, PM ;
Walker, GJ ;
Glendening, JM ;
Lin, AHT ;
Palmer, JM ;
Walters, MK ;
Hayward, NK ;
Fountain, JW .
ONCOGENE, 1997, 15 (24) :2999-3005
[10]   Melanoma incidence and mortality among US whites, 1969-1999 [J].
Geller, AC ;
Miller, DR ;
Annas, GD ;
Demierre, MF ;
Gilchrest, BA ;
Koh, HK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (14) :1719-1720